Acceliant to participate in the 'Partnerships in Clinical Trials 2010'
30 Mar, 2010
March 30 2010, Herndon, Virginia - Acceliant will be participating in the 19th Annual Partnerships in Clinical Trials 2010 at Orlando, FL from April 12-14, 2010. The event is being held at the Orlando World Center Marriott Resort and is one of the premier events for clinical outsourcing and development professionals and is increasingly valuable to those with responsibilities in clinical operations, drug safety and quality.
'Partnerships in Clinical Trials' is one of the most important events attended by several clinical professionals, leading experts and solution providers in clinical development all over the world. CEOs from leading Clinical Research Organizations will explain how to stay customer focused, view the future of CRO industry and most importantly how to survive the economic downturn.
At the event, Acceliant will be hosting an exhibit booth and presenting Acceliant eClincal Suite, its popular clinical trial solution. The Acceliant eClincal Suite defines and provides new standards for Pharmaceutical, Medical Device and Contract Research Organizations (CRO) in the area of clinical trials.
'We have 10 successful years of rich and varied experience used to develop and customize Acceliant to suit your needs. With the advent of Acceliant v6.0 in market, we are offering a complete and more sophisticated solution in the life sciences space', said President and CEO of Trianz, Sri Manchala
About Acceliant eClinical Suite
Acceliant eClinical Suite is competitive in meeting the challenges of today's dynamic market conditions. The Acceliant eClinical Suite is a pre-eminent offering that continues its 11-year history of providing innovative solutions for the life sciences industry. The Acceliant eClinical Suite is robust, scalable, and flexible. It has been proven by more than 350 Phase I-IV trials, covering all therapeutic areas and medical device trials. Engineered for agility, our service model differentiators enable us to implement and deploy in response to the data, functional, and analytic needs of clinical trials.